{
    "doi": "https://doi.org/10.1182/blood.V118.21.1090.1090",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=2005",
    "start_url_page_num": 2005,
    "is_scraped": "1",
    "article_title": "Left Ventricular Volumes, Mass and Function Normalized to the Body Surface Area, Age and Gender From CMR in a Large Cohort of Well-Treated Thalassemia Major Patients without Myocardial Iron Overload ",
    "article_date": "November 18, 2011",
    "session_type": "112. Thalassemia and Globin Gene Regulation: Poster I",
    "topics": [
        "body surface area",
        "cardiac mri",
        "cooley's anemia",
        "iron overload",
        "left ventricle",
        "myocardium",
        "anemia",
        "electrocardiogram",
        "fibrosis",
        "heart diseases"
    ],
    "author_names": [
        "Antonella Meloni, PhD",
        "Giovanni Aquaro",
        "Pierluigi Festa",
        "Francesco Gagliardotto",
        "Angelo Zuccarelli",
        "Calogera Gerardi, M.D.",
        "Michele Santodirocco",
        "Maria Antonietta Romeo, M.D.",
        "Maria Rita Gamberini",
        "Maria Paola Smacchia",
        "Giovanni Palazzi",
        "Elisabetta Chiodi",
        "Lucia De Franceschi, MD",
        "Vincenzo Positano",
        "Massimo Lombardi",
        "Alessia Pepe"
    ],
    "author_affiliations": [
        [
            "CMR Unit, Fondazione G.Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, Pisa, Italy, "
        ],
        [
            "Fondazione G.Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, Pisa, Italy, "
        ],
        [
            "Fondazione G.Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, Pisa, Italy, "
        ],
        [
            "Serv. Prevenz. Diagnosi e Cura Talassemia, Ospedale, Palermo, Italy, "
        ],
        [
            "Centro trasfusionale e di microcitemia, Ospedale civile, Olbia, Italy, "
        ],
        [
            " P.O.\u201cGiovanni Paolo II\u201d Sciacca Distretto AG2 ASP Agrigento, Sciacca, Italy, "
        ],
        [
            "Centro Microcitemia \u2013 D.H. Thalassemia, Poliambulatorio \u201cGiovanni Paolo II\u201d, Ospedale Casa Sollievo della Sofferenza IRCCS Opera di Padre Pio da Pietrelcina, san Giovanni Rotondo, Italy, "
        ],
        [
            "Dipartimento Pediatria, Azienda Policlinico, Catania, Italy, "
        ],
        [
            "Pediatria, Adolescentologia e Talassemia, Arcispedale \u201cS.Anna\u201d, Ferrara, Italy, "
        ],
        [
            "DAI PEDIATRIA \u2013 UOC Oncoematologia, Policlinico Umberto 1, Roma, Italy, "
        ],
        [
            "Oncoematologia Pediatrica, Policlinico di Modena, Modena, Italy, "
        ],
        [
            "Servizio Radiologia Ospedaliera-Universitaria, Arcispedale \u201cS. Anna\u201d, Ferrara, Italy, "
        ],
        [
            "Clinical and Experimental Med., Policlinico GB Rossi, Univ. of Vero, Verona, Italy"
        ],
        [
            "CMR Unit, Fondazione G.Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, Pisa, Italy, "
        ],
        [
            "CMR Unit, Fondazione G.Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, Pisa, Italy, "
        ],
        [
            "CMR Unit, Fondazione G.Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, Pisa, Italy, "
        ]
    ],
    "first_author_latitude": "43.7067507",
    "first_author_longitude": "10.395378149999999",
    "abstract_text": "Abstract 1090 Introduction. Cardiovascular Magnetic Resonance (CMR) allows an accurate and reproducible quantification of left ventricular (LV) parameters. In Thalassemia major (TM) patients different \u201cnormal\u201d LV values have been reported due to chronic anemia and eventually pre-existing iron burdens. Moreover, in this population it is unknown the influence of sex and age on LV parameters and no ranges of normal have been reported using MASS\u00ae software. The aim of this study was to establish the ranges for normal LV volumes, mass and ejection fraction normalized to the influence of body surface area (BSA), age and sex from CMR in a large cohort of well-treated TM patients without myocardial iron overload. Methods. Among the 923 TM patients who underwent CMR within the MIOT network for the assessment of cardiac iron overload, function and fibrosis, we selected 142 patients with no known risk factors or history of cardiac disease, normal electrocardiogram, no myocardial fibrosis and no myocardial iron overload (all the cardiac segments with a normal T2* value). All patients had been regularly transfused and chelated since early childhood. Moreover, we studied 71 healthy subjects matched for age and sex. LV function parameters were quantitatively evaluated in a standard way by SSFP cine images using MASS\u00ae software. LV end-diastolic volume, end-systolic volume, stroke volume, and mass were normalized to BSA (EDVI, ESVI, SVI, massI). Results. The table shows the comparison of the CMR parameters with differentiation for sex and age in TM patients and healthy subjects and the cut-off of normality defined as mean \u2013 or + 2 standard deviation (SD). TM patients showed significantly lower BSA than the controls (P 30 years. Significantly higher LVEF were found only for males < 14 years. In TM patients all LV volumes indexes were significantly larger in males than in females (P<0.0001 in all cases). The EF was not different between the sexes. In males the ESVI and the EF were significant different among the age groups (P=0.006 and P=0.001, respectively). In females no significant differences were detected among the age groups.  . <14 . 14\u201320 . 20\u201330 . 30\u201340 . >=40 . . TM . H . P . TM . H . P . TM . H . P . TM . H . P . TM . H . P . Males  N=7  N=7   N=6  N=6   N=25  N=15   N=23  N=11   N=6  N=5   EDVI (ml/m2) 94 \u00b1 18 (130) 75 \u00b1 11 0.034  96 \u00b1 20 (136) 91 \u00b1 20 0.715 103 \u00b1 17 (137) 101 \u00b1 13 0.686 92 \u00b1 15 (122) 80 \u00b1 11 0.022  94 \u00b1 9 (112) 75 \u00b1 11 0.013  ESVI (ml/m2) 31 \u00b1 6 (43) 24 \u00b1 6 0.058 38 \u00b1 8 (54) 35 \u00b1 14 0.670 38 \u00b1 8 (54) 39 \u00b1 9 0.676 32 \u00b1 6 (44) 29 \u00b1 6 0.160 29 \u00b1 6 (41) 28 \u00b1 10 0.816 SVI (ml/m2) 63 \u00b1 14 (91) 51 \u00b1 7 0.050  57 \u00b1 12 (81) 56 \u00b1 8 0.868 65 \u00b1 10 (85) 62 \u00b1 9 0.433 59 \u00b1 10 (79) 51 \u00b1 10 0.027  64 \u00b1 8 (80) 47 \u00b1 8 0.007  Mass I (g/m2) 57 \u00b1 7 (71) 68 \u00b1 5 0.007  57 \u00b1 13 (83) 71 \u00b1 7 0.043  66 \u00b1 12 (90) 77 \u00b1 12 0.006  62 \u00b1 12 (86) 66 \u00b1 10 0.184 68 \u00b1 16 (100) 74 \u00b1 11 0.536 EF (%) 66 \u00b1 4 (58) 54 \u00b1 6 <0.0001  60 \u00b1 2 (56) 66 \u00b1 14 0.322 63 \u00b1 3 (57) 62 \u00b1 6 0.520 65 \u00b1 3 (59) 65 \u00b1 8 0.972 68 \u00b1 6 (56) 62 \u00b1 9 0.234 Females  N=2  N=2   N=8  N=6   N=24  N=6   N=33  N=8   N=8  N=5   EDVI (ml/m2) 63 \u00b1 8 (79) 62 \u00b1 4 0.951 81 \u00b1 8 (97) 80 \u00b1 9 0.866 83 \u00b1 16 (115) 78 \u00b1 9 0.499 77 \u00b1 11 (99) 79 \u00b1 10 0.669 82 \u00b1 19 (120) 77 \u00b1 16 0.614 ESVI (ml/m2) 23 \u00b1 1 (25) 22 \u00b1 8 0.823 30 \u00b1 6 (42) 31 \u00b1 3 0.789 30 \u00b1 8 (46) 30 \u00b1 4 0.883 26 \u00b1 6 (38) 29 \u00b1 7 0.216 28 \u00b1 8 (44) 28 \u00b1 12 0.974 SVI (ml/m2) 40 \u00b1 7 (54) 41 \u00b1 4 0.919 49 \u00b1 3 (55) 49 \u00b1 6 0.892 53 \u00b1 9 (71) 48 \u00b1 6 0.234 51 \u00b1 6 (63) 50 \u00b1 8 0.915 54 \u00b1 11 (76) 49 \u00b1 6 0.394 Mass I (g/m2) 34 \u00b1 3 (40) 59 \u00b1 19 0.296 47 \u00b1 8 (63) 56 \u00b1 6 0.040  53 \u00b1 9 (71) 54 \u00b1 12 0.893 52 \u00b1 9 (70) 55 \u00b1 13 0.465 51 \u00b1 12 (75) 56 \u00b1 5 0.344 EF (%) 63 \u00b1 3 (57) 46 \u00b1 17 0.388 63 \u00b1 4 (55) 62 \u00b1 4 0.694 65 \u00b1 5 (55) 62 \u00b1 3 0.137 66 \u00b1 5 (56) 63 \u00b1 7 0.271 66 \u00b1 4 (58) 63 \u00b1 7 0.254 . <14 . 14\u201320 . 20\u201330 . 30\u201340 . >=40 . . TM . H . P . TM . H . P . TM . H . P . TM . H . P . TM . H . P . Males  N=7  N=7   N=6  N=6   N=25  N=15   N=23  N=11   N=6  N=5   EDVI (ml/m2) 94 \u00b1 18 (130) 75 \u00b1 11 0.034  96 \u00b1 20 (136) 91 \u00b1 20 0.715 103 \u00b1 17 (137) 101 \u00b1 13 0.686 92 \u00b1 15 (122) 80 \u00b1 11 0.022  94 \u00b1 9 (112) 75 \u00b1 11 0.013  ESVI (ml/m2) 31 \u00b1 6 (43) 24 \u00b1 6 0.058 38 \u00b1 8 (54) 35 \u00b1 14 0.670 38 \u00b1 8 (54) 39 \u00b1 9 0.676 32 \u00b1 6 (44) 29 \u00b1 6 0.160 29 \u00b1 6 (41) 28 \u00b1 10 0.816 SVI (ml/m2) 63 \u00b1 14 (91) 51 \u00b1 7 0.050  57 \u00b1 12 (81) 56 \u00b1 8 0.868 65 \u00b1 10 (85) 62 \u00b1 9 0.433 59 \u00b1 10 (79) 51 \u00b1 10 0.027  64 \u00b1 8 (80) 47 \u00b1 8 0.007  Mass I (g/m2) 57 \u00b1 7 (71) 68 \u00b1 5 0.007  57 \u00b1 13 (83) 71 \u00b1 7 0.043  66 \u00b1 12 (90) 77 \u00b1 12 0.006  62 \u00b1 12 (86) 66 \u00b1 10 0.184 68 \u00b1 16 (100) 74 \u00b1 11 0.536 EF (%) 66 \u00b1 4 (58) 54 \u00b1 6 <0.0001  60 \u00b1 2 (56) 66 \u00b1 14 0.322 63 \u00b1 3 (57) 62 \u00b1 6 0.520 65 \u00b1 3 (59) 65 \u00b1 8 0.972 68 \u00b1 6 (56) 62 \u00b1 9 0.234 Females  N=2  N=2   N=8  N=6   N=24  N=6   N=33  N=8   N=8  N=5   EDVI (ml/m2) 63 \u00b1 8 (79) 62 \u00b1 4 0.951 81 \u00b1 8 (97) 80 \u00b1 9 0.866 83 \u00b1 16 (115) 78 \u00b1 9 0.499 77 \u00b1 11 (99) 79 \u00b1 10 0.669 82 \u00b1 19 (120) 77 \u00b1 16 0.614 ESVI (ml/m2) 23 \u00b1 1 (25) 22 \u00b1 8 0.823 30 \u00b1 6 (42) 31 \u00b1 3 0.789 30 \u00b1 8 (46) 30 \u00b1 4 0.883 26 \u00b1 6 (38) 29 \u00b1 7 0.216 28 \u00b1 8 (44) 28 \u00b1 12 0.974 SVI (ml/m2) 40 \u00b1 7 (54) 41 \u00b1 4 0.919 49 \u00b1 3 (55) 49 \u00b1 6 0.892 53 \u00b1 9 (71) 48 \u00b1 6 0.234 51 \u00b1 6 (63) 50 \u00b1 8 0.915 54 \u00b1 11 (76) 49 \u00b1 6 0.394 Mass I (g/m2) 34 \u00b1 3 (40) 59 \u00b1 19 0.296 47 \u00b1 8 (63) 56 \u00b1 6 0.040  53 \u00b1 9 (71) 54 \u00b1 12 0.893 52 \u00b1 9 (70) 55 \u00b1 13 0.465 51 \u00b1 12 (75) 56 \u00b1 5 0.344 EF (%) 63 \u00b1 3 (57) 46 \u00b1 17 0.388 63 \u00b1 4 (55) 62 \u00b1 4 0.694 65 \u00b1 5 (55) 62 \u00b1 3 0.137 66 \u00b1 5 (56) 63 \u00b1 7 0.271 66 \u00b1 4 (58) 63 \u00b1 7 0.254 View Large Conclusions. In a large cohort of well-treated TM patients significant differences in LV parameters compared to controls were limited to males < 14 years and > 30 years. Due to the influence of BSA, sex and age, appropriate \u201cnormal\u201d reference ranges normalized these variables should be used to avoid misdiagnosis of cardiomiopathy in TM patients. Disclosures: No relevant conflicts of interest to declare."
}